These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12401432)

  • 1. Longitudinal prostaglandin E(2) generation in various organs during evolution of experimental portal hypertension.
    Ackerman Z; Karmeli F; Rachmilewitz D
    Prostaglandins Leukot Essent Fatty Acids; 2002 Oct; 67(4):197-201. PubMed ID: 12401432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
    Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
    World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension.
    Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
    Liver; 1996 Feb; 16(1):12-8. PubMed ID: 8868072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
    García-Pagán JC; Fernández M; Bernadich C; Pizcueta P; Piqué JM; Bosch J; Rodés J
    Am J Physiol; 1994 Dec; 267(6 Pt 1):G984-90. PubMed ID: 7810666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of estrogen in portal hypertension gastropathy: an experimental model.
    Morgan-Martins MI; Jacques SI; Hartmann RM; Marques CM; Marroni CA; Marroni NP
    Arq Gastroenterol; 2011; 48(3):211-6. PubMed ID: 21952708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
    J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful hepatic grafting after partial portal vein ligation in the rat: complete reversal of hemodynamic abnormalities.
    Zhang XY; Kuznetsova LV; Zimmermann A; Wheatley AM
    Transplantation; 2000 Jan; 69(1):3-10. PubMed ID: 10653371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats.
    Yokoyama Y; Wawrzyniak A; Sarmadi AM; Baveja R; Gruber HE; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1567-74. PubMed ID: 16928218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
    Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
    J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of liver damage on blood-borne variables and pulmonary hemodynamic responses to hypoxia and hyperoxia in anesthetized rats.
    Sepehrinezhad A; Dehghanian A; Rafati A; Ketabchi F
    BMC Cardiovasc Disord; 2020 Jan; 20(1):13. PubMed ID: 31931715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of portal pressure in the severity of bleeding in portal hypertensive rats.
    Castañeda B; Debernardi-Venon W; Bandi JC; Andreu V; Pérez-del-Pulgar S; Moitinho E; Pizcueta P; Bosch J
    Hepatology; 2000 Mar; 31(3):581-6. PubMed ID: 10706546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
    Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T
    Adv Med Sci; 2022 Mar; 67(1):154-162. PubMed ID: 35272246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
    Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
    J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine prevents oxidative stress in a model of portal hypertension.
    Zabot GP; Carvalhal GF; Marroni NP; Licks F; Hartmann RM; da Silva VD; Fillmann HS
    World J Gastroenterol; 2017 Jul; 23(25):4529-4537. PubMed ID: 28740341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.
    Mejias M; Garcia-Pras E; Tiani C; Bosch J; Fernandez M
    J Cell Mol Med; 2008; 12(5A):1690-9. PubMed ID: 18194463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.
    Fernando B; Marley R; Holt S; Anand R; Harry D; Sanderson P; Smith R; Hamilton G; Moore K
    Hepatology; 1998 Sep; 28(3):689-94. PubMed ID: 9731560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
    Licks F; Hartmann RM; Marques C; Schemitt E; Colares JR; Soares Mdo C; Reys J; Fisher C; da Silva J; Marroni NP
    World J Gastroenterol; 2015 Nov; 21(43):12351-60. PubMed ID: 26604642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mucosal resistance to acute injury in experimental portal hypertension.
    Calatayud S; Ramírez MC; Sanz MJ; Moreno L; Hernández C; Bosch J; Piqué JM; Esplugues JV
    Br J Pharmacol; 2001 Jan; 132(1):309-17. PubMed ID: 11156591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.